A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)
NCT06189391
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Interventions
DRUG:
MK-1045
Sponsor
MSD R&D (China) Co., Ltd.